Cytotoxicity and in vitro antileishmanial activity of antimony (V), bismuth (V), and tin (IV) complexes of Lapachol

Bioinorganic Chemistry and Applications

Volumn 2013, Issue , 2013, Pages

  Rocha, Marcele Neves ^a   Nogueira, Paula Monalisa ^a   Demicheli, Cynthia ^b   De Oliveira, Ludmila Gonçalvez ^b   Da Silva, Meiriane Mariano ^b   Frézard, Frédéric ^b   Melo, Maria Norma ^b   Soares, Rodrigo Pedro ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878667814     PISSN: 15653633     EISSN: 1687479X     Source Type: Journal    
DOI: 10.1155/2013/961783     Document Type: Article

References (35)

1. Bittencourt A., Barral A., de Jesus A. R., de Almeida R. P., Grimaldi Júnior G., In situ identification of Leishmania amazonensis associated with diffuse cutaneous leishmaniasis in Bahia, Brazil. Memórias do Instituto Oswaldo Cruz 1989 84 4 585 586 2-s2.0-0024753238
2. Croft S. L., Sundar S., Fairlamb A. H., Drug resistance in leishmaniasis. Clinical Microbiology Reviews 2006 19 1 111 126 2-s2.0-31544439919 10.1128/CMR.19.1.111-126.2006 (Pubitemid 43157649)
3. Croft S. L., Seifert K., Yardley V., Current scenario of drug development for leishmaniasis. Indian Journal of Medical Research 2006 123 3 399 410 2-s2.0-33745196673 (Pubitemid 43905578)
4. Mishra J., Saxena A., Singh S., Chemotherapy of leishmaniasis: past, present and future. Current Medicinal Chemistry 2007 14 10 1153 1169 2-s2.0-34247579197 10.2174/092986707780362862 (Pubitemid 46679457)
5. Lima N. M. F., Correia C. S., Leon L. L., Machado G. M. C., de Fátima Madeira M., Santana A. E. G., Goulart M. O. F., Antileishmanial activity of lapachol analogues. Memórias do Instituto Oswaldo Cruz 2004 99 7 757 761 2-s2.0-14044263605 (Pubitemid 40278172)
6. Andrews P. C., Ferrero R. L., Junk P. C., Kumar I., Luu Q., Nguyen K., Taylor J. W., Bismuth(iii) complexes derived from non-steroidal anti-inflammatory drugs and their activity against Helicobacter pylori. Dalton Transactions 2010 39 11 2861 2868 2-s2.0-77749254633 10.1039/c000164c
7. Raychaudhury B., Banerjee S., Gupta S., Singh R. V., Datta S. C., Antiparasitic activity of a triphenyl tin complex against Leishmania donovani. Acta Tropica 2005 95 1 1 8 2-s2.0-20444385092 10.1016/j.actatropica.2005.03.008 (Pubitemid 40805015)
8. Andrews P. C., Frank R., Junk P. C., Kedzierski L., Kumar I., MacLellan J. G., Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates. Journal of Inorganic Biochemistry 2011 105 3 454 461 2-s2.0-79952991662 10.1016/j.jinorgbio.2010.08.007
9. Oliveira L. G., Silva M. M., Paula F. C., Pereira-Maia E. C., Donnici C. L., Simone C. A., Frezard F., Silva E. N. Jr., Demicheli C., Antimony(V) and bismuth(V) complexes of lapachol: synthesis, crystal structure and cytotoxic activity. Molecules 2011 16 12 10314 10323
10. Rocha M. N., Margonari C., Presot I. M., Soares R. P., Evaluation of 4 polymerase chain reaction protocols for cultured Leishmania spp. typing. Diagnostic Microbiology and Infectious Disease 2010 68 4 401 409 2-s2.0-78649331772 10.1016/j.diagmicrobio.2010.08.007
11. Soares R. P. P., Macedo M. E., Ropert C., Gontijo N. F., Almeida I. C., Gazzinelli R. T., Pimenta P. F. P., Turco S. J., Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Molecular and Biochemical Parasitology 2002 121 2 213 224 2-s2.0-0036275269 10.1016/S0166-6851(02)00033-6 (Pubitemid 34603406)
12. Ernest D. O. D. V. M., Brenda M. C. D. V. M., McWilliam A. A., Guide to the Care and Use of Experimental Animals 1993 Canadian Council on Animal Care
13. Rocha M. N., Correa C. M., Melo M. N., Beverley S. M., Martins-Filho O. A., Madureira A. P., Soares R. P., An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein. Diagnostic Microbiology and Infectious Diseases 2013 75 3 282 291
14. Berman J. D., Lee L. S., Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages. Journal of Parasitology 1984 70 2 220 225 2-s2.0-0021145297 (Pubitemid 14069105)
15. Pinheiro A. C., Rocha M. N., Nogueira P. M., Nogueira T. C., Jasmim L. F., de Souza M. V., Soares R. P., Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines. Diagnostic Microbiology and Infectious Disease 2011 71 3 273 278
16. Darlington G. J., Kelly J. H., Buffone G. J., Growth and hepatospecific gene expression of human hepatoma cells in a defined medium. In Vitro Cellular & Developmental Biology 1987 23 5 349 354 2-s2.0-0023338271
17. Denizot F., Lang R., Rapid colorimetric assay for cell growth and survival-modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. Journal of Immunological Methods 1986 89 2 271 277 2-s2.0-0022445670 (Pubitemid 16080782)
18. Madureira M. C., Martins A. P., Gomes M., Paiva J., Cunha A. P., Rosário V., Antimalarial activity of medicinal plants used in traditional medicine in S. Tomé and Príncipe islands. Journal of Ethnopharmacology 2002 81 23 29 (Pubitemid 34518467)
19. Oliveira I., Sousa A., Morais J. S., Ferreira I. C. F. R., Bento A., Estevinho L., Pereira J. A., Chemical composition, and antioxidant and antimicrobial activities of three hazelnut (Corylus avellana L.) cultivars. Food and Chemical Toxicology 2008 46 5 1801 1807 2-s2.0-40849137515 10.1016/j.fct.2008.01.026
20. Nwaka S., Hudson A., Innovative lead discovery strategies for tropical diseases. Nature Reviews Drug Discovery 2006 5 11 941 955 2-s2.0-33750531864 10.1038/nrd2144 (Pubitemid 44660607)
21. Ioset J. R., Brun R., Wenzler T., Kaiser M., Yardley V., Drug screening for kinetoplastids diseases: a training manual for screening in neglected diseases. DNDi and Pan-Asian Screening Network 2009 1 74
22. Sereno D., Cordeiro da Silva A., Mathieu-Daude F., Ouaissi A., Advances and perspectives in Leishmania cell based drug-screening procedures. Parasitology International 2007 56 1 3 7 2-s2.0-33847238758 10.1016/j.parint. 2006.09.001
23. Chirac P., Torreele E., Global framework on essential health R&D. The Lancet 2006 367 9522 1560 1561 2-s2.0-33646368910 10.1016/S0140-6736(06)68672-8 (Pubitemid 43674241)
24. Pink R., Hudson A., Mouriès M. A., Bendig M., Opportunities and challenges in antiparasitic drug discovery. Nature Reviews Drug Discovery 2005 4 9 727 740 2-s2.0-26044468809 10.1038/nrd1824 (Pubitemid 43090494)
25. Moran M., Guzman J., Ropars A. L., McDonald A., Jameson N., Omune B., Ryan S., Wu L., Neglected disease research and development: how much are we really spending? PLoS Medicine 2009 6 2 2-s2.0-61449194131 10.1371/journal.pmed. 1000030 e1000030
26. Siqueira-Neto J. L., Song O. R., Oh H., Sohn J. H., Yang G., Nam J., Jang J., Cechetto J., Lee C. B., Moon S., Genovesio A., Chatelain E., Christophe T., Freitas-Junior L. H., Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. PLOS Neglected Tropical Diseases 2010 4 5, article e675
27. de Muylder G., Ang K. K. H., Chen S., Arkin M. R., Engel J. C., McKerrow J. H., A screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit. PLoS Neglected Tropical Diseases 2011 5 7 2-s2.0-79960945898 10.1371/journal.pntd. 0001253 e1253
28. de Miranda F. G., Vilar J. C., Alves I. A., Cavalcanti S. C., Antoniolli A. R., Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacology 2001 1 1, article 6 2-s2.0-0642369787
29. Andrade-Neto V. F., Brandão M. G. L., Oliveira F. Q., Casali V. W. D., Njaine B., Zalis M. G., Oliveira L. A., Krettli A. U., Antimalarial activity of Bidens pilosa L. (Asteraceae) ethanol extracts from wild plants collected in various localities or plants cultivated in humus soil. Phytotherapy Research 2004 18 8 634 639 2-s2.0-4944234076 10.1002/ptr.1510 (Pubitemid 39329713)
30. Pinto A. V., de Castro S. L., The trypanocidal activity of naphthoquinones: a review. Molecules 2009 14 11 4570 4590 2-s2.0-73349111624 10.3390/molecules14114570
31. Matés J. M., Sánchez-Jiménez F. M., Role of reactive oxygen species in apoptosis: implications for cancer therapy. The International Journal of Biochemistry & Cell Biology 2000 32 2 157 170 (Pubitemid 30001819)
32. Parrilha G. L., Vieira R. P., Campos P. P., Silva G. D. F., Duarte L. P., Andrade S. P., Beraldo H., Coordination of lapachol to bismuth(III) improves its anti-inflammatory and anti-angiogenic activities. BioMetals 2012 25 1 55 62 2-s2.0-79961118874 10.1007/s10534-011-9481-y
33. Tonholo J., Freitas L. R., de Abreu F. C., Azevedo D. C., Zani C. L., De Oliveira A. B., Goulart M. O. F., Electrochemical properties of biologically active heterocyclic naphthoquinones. Journal of the Brazilian Chemical Society 1998 9 2 163 169 2-s2.0-3042932965 (Pubitemid 128539782)
34. Benites J., Valderrama J. A., Rivera F., Rojo L., Campos N., Pedro M., José Nascimento M. S., Studies on quinones-part 42: synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines. Bioorganic and Medicinal Chemistry 2008 16 2 862 868 2-s2.0-38549171048 10.1016/j.bmc.2007.10.028 (Pubitemid 351163060)
35. Hillard E. A., de Abreu F. C., Ferreira D. C. M., Jaouen G., Goulart M. O. F., Amatore C., Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds. Chemical Communications 2008 23 2612 2628 2-s2.0-44849084454 10.1039/b718116g (Pubitemid 351795574)